Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases

  • Singh A
  • Nunes J
  • Ateeq B
  • 43


    Mendeley users who have this article in their library.
  • 10


    Citations of this article.


G-protein-coupled receptors (GPCRs) comprise a large family of cell-surface receptors, which have recently emerged as key players in tumorigenesis, angiogenesis and metastasis. In this review, we discussed our current understanding of the many roles played by GPCRs in general, and particularly Angiotensin II type I receptor (AGTR1), a member of the seven-transmembrane-spanning G-protein coupled receptor superfamily, and its significance in breast cancer progression and metastasis. We have also discussed different strategies for targeting AGTR1, and its ligand Angiotension II (Ang II), which might unravel unique opportunities for breast cancer prevention and treatment. For example, AGTR1 blockers (ARBs) which are already in clinical use for treating hypertension, merit further investigation as a therapeutic strategy for AGTR1-positive cancer patients and may have the potential to prevent Ang II-AGTR1 signalling mediated cancer pathogenesis and metastases.

Author-supplied keywords

  • ACE
  • AGTR1
  • Breast cancer
  • GPCR
  • Metastases

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Anukriti Singh

  • Jessica J. Nunes

  • Bushra Ateeq

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free